INTRODUCTION
Pulmonary Thromboembolism (PTE) can be defined as blocking of the pulmonary artery or one of its branches with materials (thrombus, tumor, air or fat) from another part of the body (1) (2) (3) . PTE is a disease that is commonly seen in the chest diseases practice and has a mortality rate of 10-15% within the first three months period after the diagnosis (4, 5) . There is no single laboratory marker for definite diagnosis of PTE. Therefore, studies are mostly focused on an ideal marker that provides a diagnosis. Ideal prognostic and diagnostic markers should be easily evaluated and tested. Methemoglobin (MetHb) and Carboxyhemoglobin (COHb) are values that can easily be measured in the blood gas.
TANAFFOS 26 Methemoglobin and Carboxyhemoglobin Levels and Pulmonary Embolism
Tanaffos 2019; 18 (1) : [25] [26] [27] [28] [29] [30] [31] [32] [33] Carbon monoxide (CO) can bind to the place in the hemoglobin (Hb) molecule that oxygen binds and thus remove oxygen from hemoglobin (6) . Increased exhaled CO is seen in inflammatory pulmonary diseases such as bronchiectasis and upper respiratory infection (7). Studies have shown that COHb amount could be related with the severity of acute ischemic diseases (8). Increased COHb levels have been reported for critical diseases including PTE (7,9). CO is produced endogenously by the heme oxygenase enzyme group. Heme oxygenase enzyme is stimulated with cytokines and Nitric Oxide (NO). In hemoglobin catabolism 3 enzymes act such as;
hemoxgenase-1, hemoxygenase-2 and hemoxygenase-3 (7,9-11). Hemoxgenase-1 (HO-1); can be induced by biochemical or biophysical stress and is the common isoform of the enzyme (12). It is densely present in vascular endothelium, smooth muscle, spleen and liver. Most known stimulators of HO-1 are; heme and heme derivatives, heat shock, heavy metals, NO, NO donors, oxygenated lipids, hyperoxygenemia, oxidative stress, cytokines, strong light, and glucose absence (7,9-13).
Increase in HO-1 is a sign of oxidative stress as a general indicator (10).
In order for hemoglobin to bind reversibly with oxygen and carry oxygen to tissues, iron should be kept in ferric (Fe 2+) form. Hemoglobin in Ferric (Fe 3+) form which has oxidized iron atom and is unable to bind oxygen is called MetHb (14) (15) (16) (17) . In some medical conditions such as painful attacks that are seen in sepsis, gastrointestinal infections and sickle cell anemia, MetHb could occur due to contact with toxic agents and chemical substances. Hypoxia and oxidative stress are known to increase MetHb formation (15) (16) (17) (18) (19) .
Nitric Oxide Synthase (NOS) activation, hypoxemia and oxidative stress due to PTE could cause endogenous increase in MetHb (14-16).
Our objective was to investigate whether COHb and MetHb levels were contributed to PTE diagnosis and prognosis in patients who were examined for PTE in our center.
MATERIALS AND METHODS
This is a retrospective study to investigate the effects of from the hospital automation system were recorded.
Demographic characteristics and clinical information of patients were collected twice in our hospital. We examined both forms of medical records (handwritten and electronic). In the event of unrecorded data or if any discrepancy appeared in either one of the sources, the respective case was rejected.
The patients were divided into two groups. Cases that were confirmed with PTE diagnosis using CT Pulmonary Angiography (CTPA) or Ventilation/Perfusion Scintigraphy were accepted as pulmonary embolism. And the patients which were excluded using the same methods were accepted as the control group. CTPA and V/P scintigraphy reports were given by expert radiologists. 
Data evaluation
Results were reported as the mean ± SD and categorical variables were given as percentages. 
Ethics of the Study
The study was approved by the Ethics Board of School of Medicine of Akdeniz University.
RESULTS
In our study, totally 462 patients were evaluated for PTE pre-diagnosis. In 302 patients PTE diagnosis was verified, whereas in 160 patients PTE was excluded. In PTE group 228 patients and in other group 127 patients were excluded from the study because of various causes (being smoker, lack of data, comorbidities such as COPD). Finally total 107 patients having inclusion criteria were included in the study (Figure1).
Basic clinical and laboratory characteristics of the patients enrolled in the study are shown in When biochemistry and hemogram results of the group diagnosed with PTE and group excluded for PTE diagnosis were compared, while fibrinogen levels (P=0.029) were significantly higher in the group diagnosed with PTE, no significant difference in other parameters was found between these two groups. When the blood gas parameters of both groups were compared, COHb levels in the groups with PTE diagnosis were statistically significantly higher (P=0.001), and the PO 2 levels in the group excluded for PTE diagnosis were statistically significantly higher (P=0.028) ( Table 3) . There is no single laboratory marker for definite diagnosis of PTE. Therefore, studies are mostly focused on an ideal marker that provides a diagnosis. Ideal prognostic and diagnostic markers should be easily evaluated and COHb values were found to be significant (9). However, our study found that MetHb and COHb levels did not contribute to the diagnosis and prognosis of PTE.
In our study, COHb values were significantly higher in patients diagnosed with pulmonary embolism versus patients who were excluded for pulmonary embolism. The mean COHb value in the normal healthy population is between 0.3-2.6%. Although this value was in the normal range, it was significantly higher when compared with the control group. In the analysis of pulmonary embolism subgroup, when patients with non-massive PTE diagnosis
were compared with patients with massive and submassive PTE diagnosis, no significant difference was found between COHb levels. In the study by Kakavas et al.,
COHb values in patients diagnosed with high risk (massive PTE + sub-massive PTE) PTE were low, however, our study does not support this. COHb levels were low in mortality patients in Kakavas et al's study (9). Therefore, they reported that COHb levels could be used as a marker in the prognosis of acute PTE. However, our study did not find any significant difference in COHb levels of our mortality and survived patients.
No significant difference in MetHb values was found
between the group with PTE diagnosis and the group excluded for PTE diagnosis. When we look at the subgroup analysis of the group diagnosed with PTE, the low risk group and medium and high risk groups were compared and no significant difference was found for MetHb levels. Kakavas et al. reported that MetHb levels could rise in the high risk group with PTE diagnosis (9).
However, our study did not find any correlation between MetHb and PTE. We believe that the reason for the positive correlation between MetHb and PESI in the study of Kakavas et al. was the extensive inclusion criteria. In literature Schuerholz et al. (18) found that MetHb levels were associated with severity of sepsis. Yasuda et al.
(7,28) reported that COHb levels were higher in asthma, COPD and idiopathic pulmonary fibrosis than control group. Mall et al. (8) found that COHb was higher in ischemic heart diseases. As a result of these studies COHb and MetHb levels were described as being associated with severity of disease. In our study in PTE (in contrast to other lung diseases) COHb and MetHb levels were not correlated with disease severity.
Our study had its own limitations. The main limitation of this study is its retrospective observational design.
Consequently, the data of a few patients could not be retrieved. However, it was possible to verify the data included in our study from different sources (medical records hand written and electronic), and therefore, we consider them to be adequately precise. An additional limitation was the small number of patients in each 
CONCLUSION
Consequently PTE is a frequent disease that could result in mortality. In our study, COHb level was found to be statistically significant in the group with PTE. However, this value was not higher than the normal COHb level in the blood. Different from the only study in the literature, we found that MetHb and COHb levels were not statistically significant in the prognosis of PTE. We think that this difference is caused by the characteristics of the patient population. We believe that, this should be supported with prospective studies.
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